← All procedure guides

Rheumatoid arthritis treatment and management (Management of rheumatoid arthritis)

The ongoing, specialist-led plan to control rheumatoid arthritis, ease symptoms and protect joints using medicines, monitoring and support, rather than a one-off treatment.

✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review

In short

  • RA management is an ongoing plan to control inflammation and protect joints, not a one-off treatment, and it works best when started early.
  • The aim is low disease activity or remission, but treatment controls rather than cures RA, and the plan often needs adjusting over time.
  • Most medicines used (DMARDs and biologics) need regular monitoring blood tests and carry some infection risk, which is part of the trade-off.
  • Good care means regular reviews, a clear plan for flares, and shared decisions, rather than simply taking a tablet and hoping.

A plain-English summary. The detail — including risks and recovery — is below.

At a glance

TypeLong-term, specialist-led treatment plan
AnaestheticNot applicable
How long it takesAn ongoing programme, not a single appointment
Hospital stayManaged in clinics and at home; hospital stays are unusual and only if complications arise
Time off workUsually none for routine care; flares or starting new medicines may need short adjustments
When you'll see resultsSymptoms often improve over weeks to a few months; the aim is low disease activity or remission, judged at reviews
On the NHS?Rheumatoid arthritis care is core NHS work; private care is used for speed, choice of specialist or convenience

A general guide. Your specialist will give you advice for your situation.

Best fit

Can reduce joint pain, swelling and morning stiffness

Pause if

A particular medicine may not suit you because of liver, kidney, lung or blood problems, or a current infection.

Main recovery point

Disease-modifying medicines often take several weeks to start working. A short steroid course may be used to settle symptoms in the meantime. Early blood...

Good aftercare

Regular review of disease activity with a clear target.

First weeks of a new medicine

Disease-modifying medicines often take several weeks to start working. A short steroid course may be used to...

Around 6 to 12 weeks

Your team reviews early response: less pain, swelling and morning stiffness, and improving blood markers. The dose...

3 to 6 months

The aim is to be reaching low disease activity or remission. If not, treatment is stepped up, which may mean...

Ongoing reviews

Regular appointments check disease activity, side effects and monitoring bloods. Treatment is adjusted over time...

Medical line illustration of rheumatology joint inflammatory disease for Rheumatoid arthritis treatment and management.
Illustration only - not a diagnosis, medical advice or a promise of result. Your anatomy and treatment plan may differ. Vuemedics does not publish before-and-after photos.

What is rheumatoid arthritis management?

Rheumatoid arthritis (RA) is a long-term condition where the immune system attacks the lining of joints, causing pain, swelling and stiffness, often in the hands, wrists and feet. Without treatment it can damage joints and affect other parts of the body, and it can cause fatigue and flares.

'Management' means the whole plan to keep RA under control, not a single treatment. It usually combines medicines that calm the immune system, regular monitoring, support from a rheumatology team, and help with exercise, work and daily life. A rheumatologist usually leads this, with a specialist nurse and GP involved.

Modern care follows a 'treat to target' idea: start effective medicine early, measure disease activity regularly, and adjust treatment until you reach low disease activity or remission (few or no signs of active inflammation). This early, active approach is what best protects joints over time.

It is important to be realistic. Treatment can control RA very well for many people, but it does not cure it. Medicines have trade-offs, including monitoring and infection risk, and the plan often needs adjusting over the years. Good management is about working with your team, not finding a single fix.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Conventional DMARDs
Disease-modifying drugs such as methotrexate, sulfasalazine, leflunomide and hydroxychloroquine, used to calm the immune system and protect joints. Methotrexate is usually the first choice.
Biologic and targeted medicines
Used when conventional DMARDs are not enough. These include anti-TNF and other biologics (by injection or infusion) and targeted tablets (JAK inhibitors), which block specific parts of the immune response.
Steroids
Used short-term, as tablets, injections into a joint, or a one-off injection, to settle a flare or bridge the gap while longer-term medicines take effect. Not ideal for long-term use.
Pain relief and anti-inflammatories
Painkillers and NSAIDs help with symptoms but do not change the disease itself, so they are used alongside, not instead of, disease-modifying treatment.
Support and rehabilitation
Physiotherapy, occupational therapy, podiatry, exercise, help with work, and support for fatigue and mental wellbeing are an important part of the plan.

Symptom relief versus disease control

Painkillers/NSAIDsDMARDs/biologics
Eases painYes, fairly quicklyYes, more slowly
Changes the diseaseNoYes
Protects jointsNoYes
Needs blood monitoringSometimesUsually

Painkillers help you feel better day to day but do not stop joint damage. Disease-modifying treatment is what protects the joints, so the two are usually used together.

Preparing for your treatment

  • Bring a list of your symptoms, which joints are affected, how long stiffness lasts in the morning, and how RA affects your work and daily life.
  • Bring all your medicines and supplements, and a note of any allergies or past drug reactions.
  • Have any recent blood tests, X-rays or scans available, and previous clinic letters if you have them.
  • Tell the team about other health conditions, especially infections, liver, kidney or lung problems.
  • Sort out vaccinations where you can, as some medicines mean avoiding live vaccines; flu and recommended COVID-19 vaccines are encouraged.
  • Tell the team if you could be pregnant, are planning pregnancy or are breastfeeding, as this affects medicine choice.
  • Think about your goals and questions, such as work, exercise, family planning and how active you want to be.

What happens

At a rheumatology appointment, the clinician asks about your symptoms, examines your joints for swelling and tenderness, and may use a disease-activity score to measure how active the RA is. Blood tests and sometimes scans help confirm the picture.

Together you agree a treatment plan. This usually starts effective disease-modifying medicine early, often methotrexate, sometimes with a short course of steroid to settle things quickly. You are told how the medicine is taken, what monitoring it needs, and what side effects to watch for.

You are then reviewed regularly. At each review your team checks how active the RA is, how you are tolerating treatment, and your monitoring blood tests, and adjusts the plan, stepping treatment up if disease is still active, or carefully down if you are doing very well. Between appointments you should have a way to contact the team about flares or problems.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

May not be suitable if…

  • A particular medicine may not suit you because of liver, kidney, lung or blood problems, or a current infection.
  • Some medicines are not suitable in pregnancy, breastfeeding or when planning a family.
  • Strong immune-dampening treatment may be the wrong choice if disease activity is genuinely low.
  • If symptoms are not actually due to active RA, a different diagnosis or specialty may be needed.
  • Private-only care may not suit you if you need the full multidisciplinary support of an NHS team.

Delay or rearrange if…

  • You currently have an infection or are on antibiotics, before starting or escalating immune-dampening treatment.
  • Your baseline blood tests or screening are incomplete.
  • You are due, or have just had, a live vaccine.
  • You could be pregnant, or are planning pregnancy, and medicines have not been reviewed.
  • You have an operation planned, so medicine timing can be coordinated.

Alternatives to discuss

  • Different DMARDs or combinations if the first choice does not suit or work.
  • Biologic or targeted (JAK inhibitor) medicines if conventional DMARDs are not enough.
  • Short-term steroids or joint injections for flares rather than long-term steroids.
  • Physiotherapy, occupational therapy, podiatry, exercise and lifestyle support alongside medicines.
  • Surgery in selected people with severe joint damage, after medical options.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

What matters most to me?

Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.

What are all my options?

Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.

What would make me pause?

Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.

What happens if I do nothing today?

For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.

Benefits

  • Can reduce joint pain, swelling and morning stiffness
  • Can slow or prevent joint damage and protect long-term function
  • Can improve fatigue, mobility and ability to work and stay active
  • Aims for low disease activity or remission for many people
  • Provides ongoing monitoring so problems and flares are picked up and managed
  • Supports the whole person, including work, mental wellbeing and family planning

Risks & complications

More common
  • Side effects from medicines, such as nausea, mouth ulcers or tiredness with methotrexate
  • A higher chance of infections, because many RA medicines dampen the immune system
  • The need for regular monitoring blood tests, which is inconvenient but important
  • Flares, where symptoms worsen for a time despite treatment
Less common
  • Liver, blood-count or kidney changes shown on monitoring blood tests
  • More serious infections needing antibiotics or hospital treatment
  • Needing to switch medicines because one does not work well enough or is not tolerated
  • Steroid side effects if steroids are used for too long
Rare but serious
  • Serious medicine reactions, such as lung inflammation with methotrexate
  • Reactivation of a hidden infection such as tuberculosis or hepatitis with some treatments
  • Effects on the lungs, eyes, heart or blood vessels from RA itself if it is poorly controlled
  • Rare but serious complications of specific medicines, which your team will explain

The main trade-offs in RA care are between controlling the disease and the monitoring and infection risks of the medicines that do this. Poorly controlled RA also carries its own risks to joints and other organs, so doing nothing is rarely the safer option. Ask your team how each medicine will be monitored, what to do when you get an infection, and how the plan fits with any pregnancy plans.

Published figures to discuss

How well treatment works, and how likely side effects are, varies with the individual, the medicines used, how active the disease is and other health conditions. Remission is achievable but not guaranteed, and is reached by a minority in some studies despite good treatment. Because of this variation, outcomes and risks should be discussed as cautious, individual estimates rather than fixed figures.

FigureReported rangeHow to interpret itSource / confidence
Best window for starting disease-modifying treatmentGuidelines emphasise early treatment, ideally within months of persistent synovitis being recognisedDelay matters because joint damage can start early; painkillers alone do not protect joints.NHS — Rheumatoid arthritis treatmentnhs.ukSource-linked context
Time for methotrexate or another conventional DMARD to show clear benefitOften around 6 to 12 weeksEarly steroid bridging may help symptoms, but the long-term target is disease control with DMARDs and regular review.Guide sourcesClinical context
Remission or low disease activity with treat-to-target careAchievable for many, but not guaranteed; trial and registry estimates vary widelyThe important quality marker is measured disease activity and treatment adjustment when the target is not reached.Guide sourcesClinical context
Serious infection on biologic or targeted treatmentUncommon but increased compared with no immune-dampening treatmentScreening for TB/hepatitis, vaccination review and advice about pausing treatment during infection are part of consent.NHS — Rheumatoid arthritis treatmentnhs.ukSource-linked context

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

This is ongoing care rather than a procedure with a recovery period. What matters is how your symptoms and disease activity change over weeks to months, and how the plan is reviewed and adjusted over time.

First weeks of a new medicine
Disease-modifying medicines often take several weeks to start working. A short steroid course may be used to settle symptoms in the meantime. Early blood tests check you are tolerating the medicine.
Around 6 to 12 weeks
Your team reviews early response: less pain, swelling and morning stiffness, and improving blood markers. The dose may be increased or another medicine added if the RA is still active.
3 to 6 months
The aim is to be reaching low disease activity or remission. If not, treatment is stepped up, which may mean adding or switching to a biologic or targeted medicine.
Ongoing reviews
Regular appointments check disease activity, side effects and monitoring bloods. Treatment is adjusted over time, and occasionally carefully reduced if you do very well.
During a flare
Symptoms can worsen for a time. A flare plan, such as contacting the team, a steroid course or a joint injection, helps settle it and decide whether the longer-term plan needs changing.
What's normal — and not a worry
  • A gradual rather than sudden improvement in pain and stiffness over weeks
  • Some good days and worse days, especially early on or during a flare
  • Mild medicine side effects that often settle, such as nausea with methotrexate
  • Needing regular blood tests as a routine part of treatment
  • Ongoing fatigue that improves as the disease comes under control

Aftercare

  • Take medicines exactly as prescribed; methotrexate, for example, is taken once a week, not daily.
  • Keep up your monitoring blood tests, as several RA medicines need regular checks.
  • Watch for signs of infection and seek advice promptly; some medicines should be paused during infections.
  • Avoid live vaccines unless your team agrees, and have flu and recommended COVID-19 vaccines.
  • Have a clear flare plan and know who to contact when symptoms worsen.
  • Keep moving with suitable exercise, and use physiotherapy, occupational therapy and podiatry as offered.
  • Tell other clinicians, dentists and surgeons what RA medicines you take.
Before your treatment
  • A clear, written treatment and flare plan
  • Monitoring blood tests booked and a system to see the results
  • Vaccinations reviewed (live vaccines avoided where needed; flu/COVID arranged)
  • A named contact route for flares, infections and questions
  • A list of your current medicines, including how and when to take them
  • Knowing what to do with your medicines if you get an infection or need an operation
  • Goals noted for work, exercise and, if relevant, family planning

⚠ Get urgent help if…

  • A high temperature, shaking chills or feeling very unwell, which may signal a serious infection
  • A new, very hot, swollen, painful joint, which needs urgent assessment to rule out joint infection
  • Breathlessness or a new troublesome cough, especially on methotrexate (possible lung problem)
  • Yellowing of the skin or eyes, very dark urine, or unusual tiredness (possible liver problem)
  • Unusual bruising, bleeding or a persistent sore throat (possible low blood counts)
  • Chest pain, leg swelling or sudden breathlessness (seek urgent help)
  • A severe or unusual headache, vision changes or new weakness (seek urgent help)

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good result is RA that is well controlled: low disease activity or remission, with few swollen or tender joints, less morning stiffness, better function and improved blood markers. This is judged over weeks to months and reviewed regularly, not from a single appointment.

Good control protects joints and quality of life, but it is not a cure. RA can still flare, medicines may need changing, and monitoring continues even when you feel well. Reaching remission does not always mean medicines can be stopped; any reduction is done carefully and under specialist guidance, because stopping too soon can let the disease return.

How long it lasts

RA is a lifelong condition, so management continues over the long term, even through periods when you feel well. Many people stay on the same plan for years, while others need their medicines changed as the disease or side effects change. A few people who reach sustained remission can, under guidance, reduce treatment, but this is monitored closely because RA can come back. The plan is reviewed over time rather than fixed.

Related tests, treatments or support

RA care is usually a combination: a disease-modifying medicine (sometimes more than one), short-term steroids or joint injections for flares, painkillers for symptoms, and support such as physiotherapy and occupational therapy. Biologics are often combined with methotrexate. Your team coordinates these so they work together safely, including around vaccinations, infections and any operations.

Follow-up & long-term care

Follow-up is regular and ongoing: reviews of disease activity, monitoring blood tests, and checks for side effects and infections. You should be able to contact your team between appointments about flares, reactions or warning signs, rather than waiting. Care is often shared between your rheumatology team and your GP, with clear arrangements for who does what.

  • Keep taking medicines as prescribed and attend monitoring blood tests.
  • Stay physically active and use rehabilitation support as offered.
  • Keep vaccinations up to date, avoiding live vaccines where needed.
  • Follow your flare plan and contact the team early when symptoms worsen.
  • Review your treatment regularly so it can be stepped up or carefully down.
  • Tell every clinician, dentist and surgeon which RA medicines you take.

Repeat, follow-on and what comes next

  • Many people need their treatment changed over time as disease activity or side effects change.
  • If a medicine does not control the disease, the usual step is to add or switch rather than simply continue.
  • Flares may need extra short-term treatment and a review of the longer-term plan.
  • Treatment may be carefully reduced if sustained remission is reached, but is restarted if the disease returns.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

  • Regular review of disease activity with a clear target.
  • Reliable monitoring blood tests with results acted on.
  • A written flare plan and a named contact route.
  • Coordinated vaccination and infection advice.
  • Multidisciplinary support, including physiotherapy, occupational therapy and help with work.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

  • The rheumatology consultation fee and the length and number of appointments
  • Blood tests and any X-rays, ultrasound or other scans
  • The medicines used, which range widely from inexpensive DMARDs to costly biologics
  • Ongoing monitoring blood tests and review appointments
  • Steroid or joint injections if needed during flares
  • Physiotherapy, occupational therapy or podiatry if arranged privately
  • Whether care is shared with the NHS or fully private
Make sure your written quote includes
  • The consultation fee and what each appointment includes
  • Which tests and scans are included, and which are extra
  • The cost of the proposed medicines and who prescribes and monitors them
  • How often reviews and monitoring blood tests will be needed
  • Whether physiotherapy, occupational therapy or injections are included
  • What happens, and what it costs, during a flare or if a medicine must be switched
  • How private and NHS care will be coordinated if relevant

On the NHS? Rheumatoid arthritis is diagnosed and managed on the NHS, including specialist review, medicines and monitoring; private care is mostly used for speed, choice of specialist or convenience rather than different treatment.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Choosing a specialist safely

  • Check the specialist is on the GMC Specialist Register for this area.
  • Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
  • You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
  • Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
  • You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Questions to ask your medical professional

Take this to your consultation. A good specialist will welcome every one of these.

  • How active is my RA, and what target are we aiming for?
  • Which medicine are you suggesting first, and why this one for me?
  • What monitoring will I need, and how often?
  • What is my flare plan, and who do I contact when symptoms worsen?
  • What should I do with my medicines if I get an infection or need an operation?
  • How does my treatment fit with any plans for pregnancy or breastfeeding?
  • When might we consider stepping treatment up to a biologic, or carefully down?
  • Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
  • Will you be the specialist who carries out my treatment, and who looks after me afterwards?
  • What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
  • What does a realistic result look like — and what can this treatment not achieve?
  • What are my options, including waiting, doing nothing for now, or choosing a different approach?
  • Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
  • What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Frequently asked questions

Can rheumatoid arthritis be cured?
No, but it can often be controlled very well. The aim is low disease activity or remission, which means few or no signs of active inflammation. Even in remission, you usually stay under review because RA can come back.
Is RA care free on the NHS?
Yes, rheumatoid arthritis care is core NHS work, including specialist review, medicines and monitoring. People sometimes use private care for a faster appointment, a particular specialist or convenience, but the treatments are the same.
Why do I need so many blood tests?
Many RA medicines need regular blood tests to check your blood counts, liver and kidneys, and to catch side effects early. This monitoring is what makes long-term treatment safer.
Why start strong medicine early?
Starting effective disease-modifying treatment early gives the best chance of protecting your joints and reaching remission. Painkillers ease symptoms but do not stop joint damage, so they are not enough on their own.
What should I do during a flare?
Follow your agreed flare plan and contact your team. Flares may be settled with a steroid course or a joint injection, and they can be a sign that the longer-term plan needs reviewing.
Can I get pregnant on RA medicines?
Some RA medicines are not safe in pregnancy (for example methotrexate), while others can be continued. Tell your team early if you are planning pregnancy so your treatment can be adjusted safely in advance.

Find a verified specialist for rheumatoid arthritis treatment and management

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NHS — Rheumatoid arthritis treatment NICE NG100 — Rheumatoid arthritis in adults: management NRAS — National Rheumatoid Arthritis Society Versus Arthritis — Rheumatoid arthritis British Society for Rheumatology — Guidelines

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.

Related guides: Disease-modifying drugs (DMARDs) · Biologic drip service (infused biologic medicines) · Psoriatic arthritis treatment and management · Ankylosing spondylitis / axial SpA treatment and management · Fibromyalgia treatment